O. S. Donirova

O. S. Donirova

Auto-generated profile, based on publicly available information

O. S. Donirova

Semashko Republican Clinical Hospital

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 November 2019 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
AKAnna Kovaleva
Anna Kovaleva
NKN. V. Kokh
N. V. Kokh
EVElena Nikolaevna Voronina
Elena Nikolaevna Voronina
ODO. S. Donirova
O. S. Donirova
EZE. M. Zelenskaya
E. M. Zelenskaya
GLGalina Lifshits
Galina Lifshits
Связь генетических факторов риска с развитием артериальной гипертонии с учётом этнических различий

30 December 2020 in Patologiya krovoobrashcheniya i kardiokhirurgiya
Verified
Journal Article
Open access
PDF file
AKAnna Kovaleva
Anna Kovaleva
NKN. Kokh
N. Kokh
EVElena Nikolaevna Voronina
Elena Nikolaevna Voronina
ОДО. С. Донирова
О. С. Донирова
EZE. Zelenskаyа
E. Zelenskаyа
ГЛГ. И. Лифшиц
Г. И. Лифшиц
Аim. To study the influence of genetic factors on the severity of essential аrteriаl hypertension (AH) clinical outcomes in patients of Russian and Buryаt ethnicity.Methods. Our study included 206 patients with а diagnosis of essential AH: 136 patients were of Russiаn аnd 70 patients were of Buryаt ethnicity. Pаtients were evаluаted for the following genotype markers; АCE, АDRB1, АDRB2, АDRB3, NOS3, АGT, EDN1, GNB3, and STK39.Results. Allele T of GNB3 was аssociаted with high blood pressure in Russiаn аnd Buryаt patients. In Buryat patients, locus rs934379 of EDN1 was аssociаted with high blood pressure, whereas allele G of the same marker was associated with increased heart damage risk. In Russians, allele I of ACE was protective towards the development of left ventricular hypertrophy.Conclusion. Our data revealed ethnogenetic differences in the genetic features of essential AH. We identified the patients severe hypertension among two etnhic group. Studying ethnic genetic markers for essential AH facilitates a greater understanding of the genetic predisposition underlying this condition. Received 2 July 2020. Revised 31 August 2020. Accepted 9 September 2020. Funding: The work is supported by grant of the Russian Foundation for Basic Research (project No. 19-315-80032). Conflict of interest: Authors declare no conflict of interest. Author contributionsConception and design: N.V. Kokh, E.M. Zelenskаyа, G.I. LifshitsData collection and analysis: A.Yа. Kovаlevа, N.V. Kokh, E.N. Voroninа, O.S. Donirovа, E.M. Zelenskаyа, A.A. Slepukhina, G.I. LifshitsStatistical analysis: N.V. KokhDrafting the article: A.Yа. Kovаlevа, N.V. Kokh, E.N. Voroninа, O.S. Donirovа, E.M. Zelenskаyа, A.A. Slepukhina, G.I. LifshitsCritical revision of the article: A.Yа. Kovаlevа, N.V. Kokh, E.N. Voroninа, O.S. Donirovа, E.M. Zelenskаyа, A.A. Slepukhina, G.I. LifshitsFinal approval of the version to be published: A.Yа. Kovаlevа, N.V. Kokh, E.N. Voroninа, O.S. Donirovа, E.M. Zelenskаyа, A.A. Slepukhina, G.I. Lifshits

14 April 2025 in Russian Cardiology Bulletin
Verified
Journal Article
Closed access
RGR.G. Gulyan
R.G. Gulyan
YRYu.K. Rytova
Yu.K. Rytova
RSR.M. Shakhnovich
R.M. Shakhnovich
DPD.V. Pevzner
D.V. Pevzner
STS.N. Tereschenko
S.N. Tereschenko
SBSergey Boytsov
Sergey Boytsov
Despite widespread elderly population, these patients are underrepresented in clinical trials. Considering the Russian prospective registry REGION-IM, the authors analyzed anamnestic, demographic and clinical characteristics of patients with acute MI over ≥ 75 years old, treatment features and in-hospital mortality. The results were compared with the data of Russian and foreign ACS registries. Patients with MI ≥75 years old in the Russian Federation are characterized by severe comorbidities, less frequent invasive treatment and prescription of necessary drugs. Elderly patients have longer patient-associated reperfusion delay, symptom-to-diagnosis and symptom-to-hospitalization time, which may be explained by atypical symptoms, mental problems and social factors. In-hospital mortality is much higher in patients ≥75 years old. Elderly patients with MI represent a high-risk group that dictates the need for active and balanced approach at all stages of treatment.

22 May 2021 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
ODO. S. Donirova
O. S. Donirova
KPKonstantin Protasov
Konstantin Protasov
BDB. A. Donirov
B. A. Donirov
EBE. V. Batunova
E. V. Batunova
Aim. To investigate the relationship of soluble ST2 (sST2) to acute heart failure (AHF) and compare the predictive value of sST2 and brain natriuretic peptide in patients with ST-elevation myocardial infarction (STEMI).Material and methods. In 136 STEMI patients, the serum sST2 concentration was determined during the first 24 hours of hospitalization. We assessed levels of sST2, N-terminal pro-brain natriuretic peptide (NT-proBNP), incidence of Killip class II-IV AHF during hospitalization, myocardial necrosis biomarkers, parameters of complete blood count and biochemical blood tests, the incidence of cardiovascular diseases and risk factors. The predictive value of sST2 for AHF development was assessed using logistic regression. ROC analysis was performed. The areas under the ROC curve were compared for sST2 and NT-proBNP. The cut-off sST2 value was determined for predicting AHF.Results. The mean sST2 level was 43,4 (33,6-73,9) ng/ml. During the followup period, AHF was diagnosed in 54 people (39,7%). The prevalence of AHF in the 1st, 2ndand 3rd tertiles of sST2 was 15,6%, 33,3% and 69,7%, respectively. The NT-proBNP levels were 319 (128-1072) pg/ml, 430 (147-1140) pg/ml and 1317 (533-2386) pg/ml. The predictive value of 3rdsST2 tertile was retained adjusted for age, sex, NT-proBNP, troponin T, creatine phosphokinase-MB, high-sensitivity C-reactive protein, hemoglobin, blood glucose, left ventricular ejection fraction. The areas under the ROC curves for sST2 and NT-proBNP were comparable (0,828 and 0,733, respectively; p=0,056). The cut-off sST2 value was 64 ng/ml, above which the odds ratio of AHF was 11,1 (95% confidence interval, 4,7-26,1.Conclusion. An increase in blood sST2 is associated with an increase in AHF (Killip II-IV) prevalence in hospitalized patients with acute STEMI. Soluble ST2 has an independent predictive value for AHF in STEMI, comparable in strength and predictive model quality to NT-proBNP. The cut-off sST2 value for AHF (>64 ng/ ml) was calculated, which provides an optimal balance of sensitivity, specificity and accuracy of the prognostic model. These data support the potential value of sST2 as a biomarker of AHF in STEMI.

7 July 2023 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
EZE. M. Zelenskaya
E. M. Zelenskaya
ODO. S. Donirova
O. S. Donirova
EVElena Nikolaevna Voronina
Elena Nikolaevna Voronina
AKAnna Kovaleva
Anna Kovaleva
KPKonstantin Protasov
Konstantin Protasov
GLGalina Lifshits
Galina Lifshits
Aim. To identify and rank factors predisposing to angina relapse in Buryat patients who underwent percutaneous intervention for acute coronary syndrome.Material and methods. The study included 142 Buryat patients who underwent coronary stenting for acute coronary syndrome. All patients received clopidogrel. The CYP2C19*2 and CYP2C19*3 alleles were determined. Efficacy endpoints were assessed according to the Academic Research Consortium-2 criteria. Laboratory parameters and concomitant omeprazole therapy were assessed.Results. This study examined in detail a group of patients with short-term angina relapse without formal signs of unstable angina. A logistic regression model was obtained that makes it possible to identify and rank independent risk factors for recurrent angina in Buryat patients. Risk factors were ranked as follows: carriage of CYP2C19*2 and/or CYP2C19*3 alleles (coefficient b1=3,489, 95% confidence interval (CI) (3,096-346,213)), treatment with omeprazole (b2=2,816, 95% CI (2,745-101,616)), male sex (b3=2,749, 95% CI (1,425-163,458)) and blood glucose level (b4=0,354, 95% CI (1,141-1,779)).Conclusion. Thus, angina pain relapse in Buryat patients is facilitated by signs significant for recurrent myocardial infarction. This study suggests that patients with recurrent angina pain without electrocardiographic deterioration and biomarker elevation may require more careful personalization of therapy.

11 November 2025 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
TPTamara Pecherina
Tamara Pecherina
GCGalina Chumakova
Galina Chumakova
YGYury Isaevich Grinshtein
Yury Isaevich Grinshtein
ODO. Yu. Donirova
O. Yu. Donirova
NZN. V. Zakharchuk
N. V. Zakharchuk
ЮГЮ. И. Гринштейн
Ю. И. Гринштейн
Hypertension (HTN) is a serious public health problem. Despite advances in diagnosis and public awareness, the percentage of controlled cases remains low, especially among men and the elderly. The main challenges are related to comorbidities such as obesity, diabetes, chronic kidney disease, and obstructive sleep apnea, which worsen the prognosis and increase the risk of cardiovascular events. The approach to HTN treatment should be individualized and take into account specific disease phenotypes and comorbidities. It is important to identify patients with increased sympathetic nervous system activity, as this group experiences the greatest difficulties in blood pressure control. Moxonidine, a centrally acting agent, selectively stimulates imidazoline receptors in the brain, causing a decrease in sympathetic activity and effective reduction in blood pressure. The need for a personalized approach to HTN therapy is driven by the growing number of patients with multiple comorbidities and complex pathogenesis. New approaches, including early initiation of combination therapy and targeted management of metabolic risk factors, will reduce cardiovascular morbidity and mortality. Moxonidine plays a key role within antihypertensive medications due to its unique mechanism of action and ability to positively impact a wide range of HTN-related pathologies